Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

START-UP's 2011 Life Science Venture Capital Survey: Biopharmaceutical Investors Let Some Sunshine In

Sep 01 2011

Related Content

Sanofi/Genzyme: Emblematic of What Big Pharma's Buying Now

Mar 01 2011

In the Midst Of A Shakeout, Biotech VCs Must Embrace New Partners, New Math

Sep 01 2010

Lilly To Cease Development Of Alzheimer's Drug

Sep 01 2010

CMEA Ventures Into Development, But Not Tied To Lilly As Expected

Jun 27 2011

As Some VCs Run On Empty, Others Are Topping Off The Tank

Jul 01 2010

Some VC Funds Have Miles To Go While Others Have Burned What's In The Tank

Jul 01 2011

Oncology Dealmaking In The Wake Of Changing Regulatory And Reimbursement Decisions

May 01 2011

START-UP's 2011 Life Science Venture Capital Survey: Device Investors Feel The Sting Of FDA, Economy And Reform

Sep 01 2011

Investing A La Carte: Making Separate Bets on Discovery and Development to Boost Near-Term Returns

Mar 01 2011

The A-List: 2010's Trend-Shaping Series A Financings

Jan 01 2011

Health Care Information Technology: Venture's New Darling?

Jun 01 2011

Atlas, CMEA Test New Biotech Model

Apr 01 2011

Biotech Backers Are Learning to Live with Exit-by-Earn-out

Mar 01 2010

Related Companies

Astria Therapeutics, Inc.

Larimar Therapeutics, Inc.

Capricor Therapeutics, Inc.

Eli Lilly and Company

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window